<DOC>
	<DOCNO>NCT02240927</DOCNO>
	<brief_summary>Pregnancy associate increase risk thrombosis among woman mechanical prosthetic heart valves.However , best anticoagulant treatment strategy pregnant patient prosthetic heart valves controversial . In study investigator want identify effective safe regimen among different anticoagulant regimen .</brief_summary>
	<brief_title>Anticoagulation Regimens Pregnant Patients With Prosthetic Heart Valves</brief_title>
	<detailed_description>Four different anticoagulant treatment regimen pregnant patient prosthetic heart valve describe . In first arm warfarin stop enoxaparine start 1mg/kg dose twice day monitor weekly anti-Xa level ( 0.7-1.2 ) first trimester follow warfarin first trimester . In second arm , patient 's warfarin consumption 5 mg pregnancy , warfarin dose decreased 2.5 mg first trimester combine enoxaparine 1mg/kg dose twice day ; adjust measurement anti-Xa level ( 0.5-1 ) weekly end 12th week pregnancy . In third arm warfarin dose decrease 4 mg first trimester combine enoxaparine give similar manner . If patient 's therapeutic warfarin dose le 5 mg pregnancy , warfarin continue dose pregnancy 4th arm . All patient follow serial transesophageal echocardiography perform 0,3,6 9. month pregnancy . Informed consent take patient . After delivery baby examine experinced pediatrician pediatric cardiologist congenital anomaly .</detailed_description>
	<mesh_term>Enoxaparin</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Pregnant patient prosthetic heart valve</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Anticoagulation</keyword>
	<keyword>Prosthetic Heart Valves</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Warfarin</keyword>
	<keyword>Thrombosis</keyword>
</DOC>